VeDepo Mitchell C, Detamore Michael S, Hopkins Richard A, Converse Gabriel L
Cardiac Regenerative Surgery Research Laboratories of the Ward Family Heart Center, Children's Mercy Kansas City, Kansas City, MO, USA.
Bioengineering Program, The University of Kansas, Lawrence, KS, USA.
J Tissue Eng. 2017 Aug 25;8:2041731417726327. doi: 10.1177/2041731417726327. eCollection 2017 Jan-Dec.
The tissue-engineered heart valve portends a new era in the field of valve replacement. Decellularized heart valves are of great interest as a scaffold for the tissue-engineered heart valve due to their naturally bioactive composition, clinical relevance as a stand-alone implant, and partial recellularization in vivo. However, a significant challenge remains in realizing the tissue-engineered heart valve: assuring consistent recellularization of the entire valve leaflets by phenotypically appropriate cells. Many creative strategies have pursued complete biological valve recellularization; however, identifying the optimal recellularization method, including in situ or in vitro recellularization and chemical and/or mechanical conditioning, has proven difficult. Furthermore, while many studies have focused on individual parameters for increasing valve interstitial recellularization, a general understanding of the interacting dynamics is likely necessary to achieve success. Therefore, the purpose of this review is to explore and compare the various processing strategies used for the decellularization and subsequent recellularization of tissue-engineered heart valves.
组织工程心脏瓣膜预示着瓣膜置换领域的一个新时代。去细胞心脏瓣膜作为组织工程心脏瓣膜的支架备受关注,这是因为它们具有天然的生物活性成分、作为独立植入物的临床相关性以及在体内的部分再细胞化。然而,在实现组织工程心脏瓣膜方面仍存在重大挑战:确保整个瓣膜小叶由表型合适的细胞进行一致的再细胞化。许多创新策略都致力于实现生物瓣膜的完全再细胞化;然而,事实证明,确定最佳的再细胞化方法,包括原位或体外再细胞化以及化学和/或机械预处理,并非易事。此外,虽然许多研究都集中在增加瓣膜间质再细胞化的各个参数上,但要取得成功,可能需要对相互作用的动力学有一个全面的了解。因此,本综述的目的是探索和比较用于组织工程心脏瓣膜去细胞化及后续再细胞化的各种处理策略。